In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Apr 2021
Historique:
received: 24 03 2021
revised: 20 04 2021
accepted: 26 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 29 5 2021
Statut: epublish

Résumé

Due to their short-range (2-500 nm), Auger electrons (Auger

Identifiants

pubmed: 33924843
pii: ijms22094622
doi: 10.3390/ijms22094622
pmc: PMC8124180
pii:
doi:

Substances chimiques

Radioisotopes 0
Platinum 49DFR088MY
Cisplatin Q20Q21Q62J

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : JSPS KAKENHI
ID : JP20J20518
Organisme : JSPS KAKENHI
ID : JP18H02774

Références

Radiat Res. 1994 Oct;140(1):55-62
pubmed: 7938455
Cancer Biother Radiopharm. 2006 Oct;21(5):528-34
pubmed: 17105425
Semin Nucl Med. 2002 Apr;32(2):133-40
pubmed: 11965608
Sci Rep. 2021 Apr 14;11(1):8140
pubmed: 33854142
Cancer Res. 1973 Dec;33(12):3091-5
pubmed: 4760525
Bioconjug Chem. 2015 Dec 16;26(12):2397-407
pubmed: 26473388
Mol Pharmacol. 2010 Jun;77(6):887-94
pubmed: 20159940
Br J Cancer. 1993 Jun;67(6):1171-6
pubmed: 8512802
Nucl Med Biol. 2020 Jan - Feb;80-81:45-56
pubmed: 31810828
Nucl Med Biol. 2017 Jan;44:31-49
pubmed: 27821344
J Nucl Med. 2005 Jan;46 Suppl 1:4S-12S
pubmed: 15653646
Radiat Res. 1987 Aug;111(2):305-18
pubmed: 3628718
PLoS One. 2016 Sep 01;11(9):e0161973
pubmed: 27583677
Int J Radiat Biol. 2016 Nov;92(11):679-685
pubmed: 27022855
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302
pubmed: 12370430
Anal Chem. 2017 Nov 7;89(21):11491-11497
pubmed: 29023104
Clin Oncol (R Coll Radiol). 2013 Oct;25(10):578-85
pubmed: 23849504
Biochem Pharmacol. 1990 Sep 15;40(6):1329-36
pubmed: 2206139
Int J Radiat Biol. 2008 Dec;84(12):1123-9
pubmed: 19061137
Clin Cancer Res. 2001 Nov;7(11):3606-12
pubmed: 11705883
Cancer Cells. 1990 Feb;2(2):35-43
pubmed: 2204382
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1352-63
pubmed: 16896663
Sci Rep. 2017 Feb 13;7:42544
pubmed: 28211920
Metallomics. 2014 Nov;6(11):2126-33
pubmed: 25306996
Chem Rev. 2016 Mar 9;116(5):3436-86
pubmed: 26865551
J Nucl Med. 1996 Apr;37(4 Suppl):19S-22S
pubmed: 8676198
J Pharmacol Exp Ther. 2006 Nov;319(2):879-86
pubmed: 16914559
Int J Radiat Biol. 2012 Dec;88(12):998-1008
pubmed: 22732063
J Clin Oncol. 1996 Jun;14(6):1787-97
pubmed: 8656247
Front Pharmacol. 2018 Nov 19;9:1331
pubmed: 30510514
Curr Drug Discov Technol. 2010 Dec;7(4):263-79
pubmed: 21034408
Neoplasia. 2003 Mar-Apr;5(2):161-9
pubmed: 12659689
Metallomics. 2011 Jun;3(6):591-9
pubmed: 21399784
Appl Radiat Isot. 2019 Jul;149:31-37
pubmed: 31005643
Radiat Res. 2007 Feb;167(2):167-75
pubmed: 17390724
Am J Nucl Med Mol Imaging. 2014 Mar 20;4(2):181-92
pubmed: 24753984
Cancer Res. 1973 Apr;33(4):813-8
pubmed: 4735238
Int J Radiat Biol. 2016 Nov;92(11):617-632
pubmed: 26926313
Cancer Res. 1975 Jun;35(6):1398-401
pubmed: 1131815
Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1275-80
pubmed: 10725641
Cytometry B Clin Cytom. 2009 Mar;76(2):79-90
pubmed: 18727058
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):827-32
pubmed: 11172966

Auteurs

Honoka Obata (H)

Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.
Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido 060-0812, Japan.
Japan Society for the Promotion of Science (JSPS), 5-3-1 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan.

Atsushi B Tsuji (AB)

Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Hitomi Sudo (H)

Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Aya Sugyo (A)

Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Katsuyuki Minegishi (K)

Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Kotaro Nagatsu (K)

Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Mikako Ogawa (M)

Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido 060-0812, Japan.

Ming-Rong Zhang (MR)

Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science (iQMS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH